United States Federal Circuit

In a patent dispute, defendant unsuccessfully appealed the district court's determination that its abbreviated new drug application (ANDA)infringes patents owned by plaintiff; however, the district court's finding that defendant's ANDA filing constituted willful infringement is reversed.

Appellate Information

• Decided 07/27/2004
• Published 07/27/2004

Judges

• Before SCHALL, GAJARSA, and DYK, Circuit Judges.

Court

• United States Federal Circuit

Counsel

• For Appellees:
  
• Dennis J. Mondolino,Morgan, Lewis & Bockius LLP, of New York, NY, argued for plaintiffs-appellees.   With him on the brief were Michael F. Hurley, Brett M. Schuman, Esther H. Steinhauer, Brian W. Nolan and Christopher S. Pennisi.   Of counsel was Thomas M. Peterson, of San Francisco, CA., Scott B. Feder, Lord, Bissell & Brook LLP, of Chicago, IL, argued for defendant-appellant.   With him on the brief were Hugh L. Moore, Hugh S. Balsam and Kevin M. Nelson.